Illness presentation and quality of life in myalgic encephalomyelitis/chronic fatigue syndrome and post COVID-19 condition: a pilot Australian cross-sectional study. — CFSMEATLAS
Illness presentation and quality of life in myalgic encephalomyelitis/chronic fatigue syndrome and post COVID-19 condition: a pilot Australian cross-sectional study.
Weigel, Breanna, Eaton-Fitch, Natalie, Thapaliya, Kiran et al. · Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024 · DOI
Quick Summary
This study compared symptoms and quality of life in people with ME/CFS, people with long COVID, and healthy controls in Australia. Both ME/CFS and long COVID patients experienced similar debilitating symptoms affecting memory, sleep, and physical function, and both groups had much lower quality of life scores than healthy people. The findings suggest that ME/CFS and long COVID are similarly serious illnesses that require comprehensive medical care.
Why It Matters
This is the first Australian study directly comparing ME/CFS and long COVID symptom presentation and functional impact, providing evidence that both conditions cause similar, severe disability. The findings support advocacy for long COVID to be recognized as a serious multi-systemic illness with care needs comparable to ME/CFS, which may improve access to appropriate medical resources and multidisciplinary treatment for both patient populations.
Observed Findings
Memory disturbances, muscle weakness, lymphadenopathy, and nausea were significantly more prevalent in ME/CFS patients compared to long COVID patients.
Light-headedness was reported as more severe, and unrefreshed sleep more frequent, in ME/CFS versus long COVID groups.
Heart palpitations were less frequent in ME/CFS than long COVID patients.
Both ME/CFS and long COVID patients scored significantly lower on all SF-36v2 and WHODAS 2.0 quality-of-life domains compared to healthy controls (p<0.001).
ME/CFS and long COVID patients' quality-of-life scores were statistically comparable to each other across all measured domains.
Inferred Conclusions
ME/CFS and long COVID share a congruent symptom burden and produce equivalently debilitating impacts on quality of life and functional capacity.
The symptom overlap between ME/CFS and long COVID suggests both conditions may benefit from similar multidisciplinary diagnostic and treatment approaches.
The severe functional impairment in both patient groups emphasizes the need for comprehensive, coordinated medical care rather than treating these as minor or self-limiting conditions.
Remaining Questions
What biological mechanisms explain the symptom overlap between ME/CFS and long COVID, and are they the same or different underlying pathophysiologies?
What This Study Does Not Prove
This study does not establish causative mechanisms underlying either condition, nor does it prove that ME/CFS and long COVID are identical diseases—only that they share similar symptom profiles and functional consequences. The cross-sectional design cannot determine whether symptoms precede or follow illness onset, and the small sample sizes limit the generalizability of findings to broader populations.